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1 |  INTRODUCTION
For individuals suffering from chronic obstructive lung dis-
ease (COPD), physical exercise is a prerequisite for adequate 
treatment and rehabilitation. It counteracts the muscle patho-
physiology inherent to the disease and improves health‐related 
quality of life and activities of daily living.1-3 Unfortunately, 
exercise training is a demanding task for such patients. The 
accompanying increase in oxygen consumption in working 
muscles rapidly exceeds the oxygen‐delivery capacity of the 
cardiopulmonary system,4 leaving muscles in a state of ox-
ygen deficiency. This occurs already at low intensities and 
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Abstract
Chronic obstructive lung disease (COPD) is associated with impaired muscle func-
tions in addition to the impaired cardiopulmonary capacity inherent to the disease. 
The purpose of this study was to compare muscular performance between COPD sub-
jects (COPD, n = 11, GOLD grade II/III; FEV1 = 53 ± 14% predicted; 61 ± 7 years) 
and healthy controls (HC, n = 12, 66 ± 8 years) in three resistance exercises with 
different complexity: (a) one‐legged knee extension (1KE), and (b) one‐ and (c) two‐
legged leg press (1LP and 2LP, respectively). For each exercise, muscular perfor-
mance was defined as repetitions to exhaustion at 60% of one‐repetition maximum or 
overall exercise volume, calculated as the sum of three exercise sets. In HC, muscu-
lar performance increased progressively with increasing physiological complexity: 
1KE < 1LP < 2LP. Using 1KE as reference value, muscular performance increased 
by 1.9 (repetitions) or 4.6‐fold (volume) in 1LP and 3.1 or 7.1‐fold in 2LP. In COPD, 
similar increases occurred going from 1KE to 1LP (1.9 or 4.4‐fold change), but not 
from 1LP to 2LP, where no further increase occurred. In conclusion, in COPD, per-
formance is impaired in exercises involving larger amounts of muscle mass (>1LP), 
advocating utilization of one‐legged resistance protocols for rehabilitation purposes.
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upon activation of small bulks of muscle (>4 kg), resulting 
in dyspnea, discomfort, and impaired exercise performance.5 
Accordingly, it is difficult to achieve necessary exercise in-
tensities to provoke muscle cell adaptations,6,7 which hinders 
efficient rehabilitative training.8,9 Despite this, whole‐body 
endurance exercise training, such as cycling or walking, is 
the most commonly applied exercise modality in pulmonary 
rehabilitation.10
Fortunately, there are ways to solve this issue and to fa-
cilitate ergogenic adaptations to exercise training in COPD 
patients. A readily available solution would be to make use 
of exercise protocols with lower physiological demands such 
as resistance exercises, activating smaller amounts of muscle 
mass.4 This strategy should ensure maximal muscle activa-
tion regardless of blood oxygenation levels, enabling activa-
tion of key cellular signaling pathways, and inducing muscle 
adaptations. In line with this, resistance training has gained 
momentum in COPD rehabilitation during the last decade, 
counteracting the muscle dysfunctions accompanying the 
disease, improving muscle strength and endurance, and in-
creasing muscle mass.11-13 However, the magnitude of these 
effects remains equivocal, with available studies displaying 
a large span of variation in training adaptations, ranging 
from negligible or trivial14,15 to substantial and highly rel-
evant.16,17 Indeed, many patients do not respond to training 
at all.8,9 To date, this heterogeneity has been ascribed patho-
physiologies accompanying the disease, such as a low‐grade 
systemic inflammation,18,19 though this is unlikely to explain 
the between‐studies variation. Rather, the heterogeneous re-
sponse patterns may result from differences in study design, 
including differences in resistance training protocols. Indeed, 
the cardiopulmonary limitations of COPD patients may call 
for specific modifications to resistance training exercises in 
order to further reduce the physiological demand.20 At pres-
ent, we know little about this perspective, with only a handful 
of studies investigating the efficacy of different resistance ex-
ercise modalities.21-23
Conventional resistance training of the legs typically in-
volves two‐legged exercises. In moderate to severe COPD, 
this is likely to involve too much muscle mass to allow for 
optimal activation (and arguably adaptation).20,24 Intuitively, 
this is readily solvable by using one‐legged resistance exer-
cises, which naturally reduces the amount of active muscle 
mass. In a recent study, unilateral resistance exercises resulted 
in superior exercise workloads using elastic bands compared 
to bilateral exercises in severe to very severe COPD (GOLD 
grade III/IV), but not in healthy subjects,22,23 though analy-
sis of interaction effect for difference in exercise workload−
leg from single‐ to two‐limb exercises and group (COPD vs 
healthy) was not performed. This complicates to examine if 
COPD patients show progressively lowered muscular per-
formance in resistance exercises with increasing complexity 
compared to healthy subjects. It also remains unknown if this 
applies to COPD of less severity (GOLD grade II/III), and if 
it is applicable to isolated resistance exercises performed in 
apparatus, perhaps exacerbated by increasing physiological 
complexities of exercises. For endurance exercises, such uni-
lateral training seems to translate into superior training adap-
tations for COPD subjects.25,26
The purpose of this study was to compare muscular per-
formance in three resistance exercises of the legs involving 
different degrees of active muscle mass in COPD and healthy 
control subjects (one‐legged knee extension, and one‐ and 
two‐legged leg press). We hypothesized that muscular per-
formance in COPD patients would be increasingly impaired 
with increasing amount of active muscle mass compared to 
healthy subjects. Muscular performance was defined as rep-
etitions to exhaustion at 60% of 1RM or overall exercise vol-
ume, both calculated as the sum of three sets for each exercise.
2 |  METHODS
The study was approved by the Regional Ethics Committee 
of the Norwegian Research Council for Science and the 
Humanities as a part of “The Granheim COPD Study” (refer-
ence nr: 2013/1094) and was preregistered at clinicaltrials.
gov (NCT02598830). All subjects signed informed consent. 
The study was conducted according to the Declaration of 
Helsinki.
2.1 | Subjects
Twelve subjects with COPD and 11 healthy control subjects 
participated in the study. For background variables, see Table 
1. COPD subjects were recruited from a pulmonary rehabili-
tation center (Granheim Lung Hospital), while healthy con-
trols were recruited through acquaintances. All subjects were 
>55  years of age. COPD subjects had GOLD stage II‐III 
(FEV1 predicted <80 to >30% and FEV1/FVC <70%) and 
did not smoke at the time of inclusion and throughout the 
test period. Healthy controls had normal lung function (FEV1 
predicted >80% and FEV1/FVC >70%). Exclusion criteria 
were unstable cardiac disorders and comorbidities that could 
impair the ability to perform lifts with the lower limbs. COPD 
subjects received medication as prescribed by their medical 
doctor (Table 1). None of the subjects utilized supplemental 
oxygen regularly. Subject characteristics unrelated to mus-
cle strength and performance were similar between groups, 
except for lung function, oxygen saturation of hemoglobin 
(SpO2), and medication use (Table 1).
2.2 | Experimental design
All subjects attended 7 days of performance testing, distrib-
uted over a period of 4 weeks. Test days were separated by 
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at least 48 hours. On day 1, subjects performed spirometry 
testing, anthropometric measurements, 4‐minute step‐test, 
and familiarization to one‐repetition maximum (1RM) tests 
in one‐legged knee extension (1KE), one‐legged leg press 
(1LP), and two‐legged leg press (2LP). On days 2‐3, sub-
jects performed 1RM tests. These data were subsequently 
utilized to calculate relative workload for tests of muscular 
performance (60% of 1RM), which were performed on days 
4‐7 (two test days for the one‐legged exercises and two test 
days for the two‐legged exercise). All tests were supervised 
by the same physical training instructor, except for spirom-
etry tests, which were conducted by the same nurse special-
ist. Apparatus settings were adjusted to the needs and were 
utilized for all tests.
2.3 | Test protocols
2.3.1 | Spirometry and anthropometry
Spirometry testing (Jaeger MasterScreen PFT; Carefusion) 
was conducted before the other physical tests. The pro-
tocol followed guidelines from the American Thoracic 
Society and the European Respiratory Society.27 COPD 
patients were tested before and after inhalation of two 
bronchodilators (salbutamol, 0.2  mg and ipratropiumbro-
mid, 20 µg). See Table 1 for values on lung function after 
optimal bronchodilation.
2.3.2 | Fitness test
Subjects performed a 4‐minute step‐test to evaluate the sub-
jects’ general fitness level. A 20‐cm high step box with a 
non‐slip rubber surface (Reebok Step; Reebok) was used. 
Subjects were asked to perform as many steps as possible 
within four minutes, placing both legs on the box with the 
hip fully extended during each step up. Moderate verbal mo-
tivation was given throughout the test. Data are presented in 
Table 1.
2.3.3 | Muscular strength
Muscular strength was measured as 1RM in one‐legged knee 
extension (Technogym, Technogym SpA), one‐ and two‐
legged leg press (Gym80 Sygnum Legpress, Gym80 mbH). 
Warm‐up consisted of 5 minutes of low‐intensity bicycling 
on a bicycle ergometer, followed by three sets of 12, 8, and 
6 repetitions with low, increasing workloads. Subsequently, 
a maximum of five 1RM attempts were conducted for each 
exercise. All three exercises were tested in two separate ses-
sions, and the best result was used for further analysis. One‐
legged muscle strength was tested on both legs, with one leg 
performing 1RM in one‐legged knee extension and the other 
leg performing 1RM in one‐legged leg press, allocated to the 
two legs in a randomized manner. On the two test days, sub-
jects alternated between starting with one‐legged exercises 
(1KE and 1LP) and two‐legged exercise (2LP), giving each 
subject an attempt for each exercise modality with fully rested 
lower limbs. In one‐legged knee extension, the 1RM attempt 
was approved if the knee angle exceeded 170°. In one‐ and 
two‐legged leg press, the 1RM attempt was approved if the 
knee angle reached 90° in the eccentric phase, with subse-
quent full extension of the knee joint in the concentric phase.
2.3.4 | Muscular performance
Muscular performance was assessed in one‐legged knee 
extension, one‐ and two‐legged leg press, and was defined 
as the number of repetitions achieved at 60% of 1RM. 
Repetitions were quantified as the total number of repeti-
tions achieved over the course of three sets, with 2 minutes 
of rest in‐between. Each of the three exercise performance 
tests was conducted twice during the test period, on sepa-
rate days. One‐legged muscular performance tests (1LP and 
1KE) were conducted within the same session, with one 
leg performing one‐legged knee extension and the other 
leg performing one‐legged leg press, allocated to the two 
legs in accordance with 1RM testing. The relative order 
T A B L E  1  Subject characteristics
 
COPD sub-
jects (n = 11)
HC subjects 
(n = 12) P
Sex (♂/♀) 5/6 5/7 .86
Age 65.5 ± 8.1 61.8 ± 6.7 .24
Height (cm) 165 ± 12 173 ± 10 .11
Weight (kg) 70.1 ± 14.5 76.4 ± 11.5 .26
BMI 25.6 ± 5.1 25.5 ± 2.6 .93
SpO2 at rest 94 ± 4% 98 ± 1% .01
Lung function
FVC (L) 2.7 ± 1.1 4.1 ± 0.8 .00
FEV1/FVC (%) 49 ± 13 72 ± 6 .00
FEV1 (% predicted) 53 ± 14 117 ± 12 .00
PEF (L/s) 4.7 ± 1.9 8.1 ± 1.7 .00
GOLD II/III 7/4 — —
Medication
Β2‐agonists 10 — —
Muscarinic antagonists 1 — —
Corticosteroids 1 — —
4‐min step‐test (steps) 92 ± 25 137 ± 25 .00
Note: Values are numbers or mean ± standard deviations.
Abbreviations: BMI, body mass index; COPD, chronic obstructive pulmonary 
disease; FEV1, forced expiratory volume in one second; FVC, forced vital ca-
pacity; HC, healthy control; PEF, peak expiratory flow; SpO2, oxygen saturation 
of hemoglobin.
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of one‐legged and two‐legged test days was randomized 
between subjects; half the subjects started with one‐legged 
testing and half the subjects started with two‐legged test-
ing. The session following one‐legged testing was always 
two‐legged testing and vice versa. For each of the three 
muscular performance tests, the best result was used for 
further analyses.
Exercises were performed as previously described. Warm‐
up consisted of 5 minutes of low‐intensity cycling on a cycle 
ergometer, followed by two sets of 12 and 8 repetitions at 
loads corresponding to 15% and 30% of 1RM, respectively. 
During muscular performance tests, subjects were instructed 
to lift at a composed and controlled pace, with no rest longer 
than 1 second in the lower or upper position. Moderate ver-
bal motivation was given to all subjects. Blood lactate con-
centration (Lactate Pro, ARKRAY Inc) and SpO2 (CMS 50F 
Oximeter, Innovo Medical) were measured at rest and after 
tests. Rating of dyspnea (Borg CR10)28 was registered imme-
diately after the test.
2.4 | Statistical analysis
Differences between groups (COPD vs healthy control sub-
jects) were assessed using unpaired Student's t‐tests for nu-
meric data and Pearson's chi‐squared test for nominal data 
(sex). Differences between independent groups with repeated 
measures were assessed using mixed‐design ANOVAs with 
groups (ie, COPD and healthy control subjects) as between‐
factor and type of exercise (1KE, 1LP, and 2LP) as within‐
group factors. When a significant F value occurred, a Sidak 
post hoc test was used to determine differences between and 
within groups. The relationship between percent difference 
in muscular performance between one‐legged knee exten-
sion and two‐legged leg press and lung function was tested 
by Pearson's correlation. Statistical significance was set at 
P < .05, and data are expressed as means ± standard devia-
tion in text and means  ±  95% confidence intervals in fig-
ures. Statistical analyses were performed using IBM SPSS 
Statistics package (version 24) and figures made using Prism 
Software (GraphPad 8).
3 |  RESULTS
3.1 | Maximal strength
In general, COPD showed lower 1RM strength than healthy 
controls (F1,21  =  5.7, P  =  .027; Figure 1). In one‐leg-
ged knee extension, COPD and healthy controls achieved 
33 ± 12 and 42 ± 9 kg, respectively (P = .052). In one‐ and 
two‐legged leg press, corresponding values were 75  ±  22 
and 98 ± 18 kg (P =  .012), and 78 ± 21 and 93 ± 17 kg 
(P = .091, measured as 1RM−leg), respectively. Within each 
of the groups, no difference was seen between 1RM‐1LP 
and 1RM−leg‐2LP performance (COPD, P  =  .656; healthy 
controls, P = .137).
3.2 | Muscular performance in 
resistance exercises
There was an interaction effect for groups and exercises on 
muscular performance, measured as both total number of rep-
etitions achieved during three sets of resistance exercises at 
60% of 1RM (F2,42 = 7.3, P = .002; Figure 2A) and as exer-
cise volume (F2,42 = 8.3, P = .001; Figure 2C). In all three 
exercises, healthy controls generally managed to conduct 
more repetitions and higher exercise volumes than COPD, 
except for in one‐legged leg press, where there was no dif-
ference in repetition to exhaustion between groups (P = .10). 
For healthy controls, muscular performance increased pro-
gressively with increasing complexity and physiological de-
mand of the exercise: 1KE < 1LP < 2LP (P <  .05; Figure 
2A,C). For COPD, a similar increase was seen going from 
one‐legged knee extension to one‐legged leg press (P = .004, 
repetitions to exhaustion; P  <  .001, exercise volume), but 
not from one‐ to two‐legged leg press, where no increase oc-
curred (P = .932, repetitions to exhaustion; P = .852, exercise 
volume; Figure 2A,C). This progressive increase was high-
lighted in a subset of analysis where we calculated one‐ and 
two‐legged leg press performance as relative performance to 
one‐legged knee extension (Figure 2B,D). In this subanalysis, 
there was a significant interaction effect for groups and exer-
cises for both repetitions to exhaustion (F1,21 = 9.2, P = .006) 
and exercise volume (F1,21  =  5.5, P  =  .029), highlighting 
that muscular performance was impaired during two‐legged 
leg press in COPD compared to healthy controls. In healthy 
controls, muscular performance in one‐legged leg press was 
1.9 ± 0.7 fold (repetitions; Figure 2B) and 4.6 ± 1.8 (volume; 
F I G U R E  1  Maximal strength per leg for healthy control and 
COPD subjects. Data are means with 95% confidence levels. 1KE, 
one‐legged knee extension; 1LP, one‐legged leg press; 2LP−leg, 
two‐legged leg press divided by two; COPD, chronic obstructive 
pulmonary disease; HC, healthy control. *Significant difference 
between groups (P < .05); #significant different from 1KE (P < .05)
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Figure 2D) fold higher than in one‐legged knee extension 
(P < .001). A further increase was seen going from one‐ to 
two‐legged leg press, which was 3.1 ± 1.6 fold (repetitions; 
Figure 2B) and 7.1 ± 3.8 fold (volume; Figure 2D) higher 
than in one‐legged knee extension (P < .001). In COPD, mus-
cular performance increased in a similar manner going from 
one‐legged knee extension to one‐legged leg press (1.9 ± 0.7 
fold, repetitions; 4.4 ± 1.3 fold, volume; P < .005) (Figure 
2B,D), with no differences between COPD and healthy con-
trols (P = .992, repetitions; P = .823, volume). However, in 
COPD, no further increase was seen going from one‐legged 
to two‐legged leg press (2.1 ± 0.7 fold higher than 1KE, repe-
titions; 5.1 ± 1.3 fold higher than 1KE, volume; P = .403 and 
0.226, respectively) (Figure 2B,D). This resulted in tenden-
cies to higher performance in two‐legged leg press relative to 
one‐legged knee extension in healthy controls compared to 
COPD subjects (3.1 vs 2.1 fold and 7.1 vs 5.1 fold, P = .055 
and 0.118, respectively; Figure 2B,D).
Chronic obstructive lung disease and healthy control 
subjects displayed similar within‐session occurrences of 
muscular fatigue, measured as differences in muscular per-
formance between set 3 and 1 in each exercise (1KE, healthy 
controls = −18%, COPD = −23%, P = .874; 1LP, healthy 
controls = −15%, COPD = −23%, P = .720; 2LP, healthy 
controls = −23%, COPD = −27%, P = .144). In a merged 
data set encompassing data from both groups, there was a 
significant correlation between differences in muscular per-
formance of one‐legged knee extension and two‐legged leg 
press and predicted FEV1 (Pearson r = .49, P = .018). This 
suggests that impaired lung function was associated with im-
paired muscular performance during two‐legged leg press.
During muscular performance tests, COPD generally dis-
played greater falls in oxygen saturation (F1,21 = 9.9, P = .005) 
and higher degrees of dyspnea (F1,21 = 9.5, P = .006) within 
each of the three different resistance exercises compared to 
healthy controls (Table 2). In both COPD and healthy con-
trol subjects, there was a significant increase in dyspnea with 
increasing complexity and physiological demands of the ex-
ercises (1KE  <  1LP  <  2LP; P  <  .001). This increase was 
not evident for oxygen saturation. Healthy controls displayed 
greater increases in blood lactate concentration from before 
to after exercises (F1,21 = 5.9, P < .05; Table 2).
4 |  DISCUSSION
The primary finding of this study is that patients with mod-
erate to severe COPD (GOLD grade II or III) display lower 
muscular performance in the legs compared to healthy con-
trols. This difference increases with the complexity of the 
exercise, that is, the amount of active muscle mass and as-
sociated increases in physiological demands. In particular, 
in COPD, muscular performance was clearly impaired going 
from one‐legged exercises to two‐legged leg press, compared 
to healthy controls. Whereas the overall reduction in muscu-
lar performance seen in COPD compared to healthy controls 
F I G U R E  2  Exercise performance 
in resistance exercises for healthy control 
and COPD subjects performed as three sets 
to exhaustion at 60% of 1RM. Exercise 
performance was measured as A, total 
number of repetitions to exhaustion, B, 
number of repetitions to exhaustion in 1LP 
and 2LP relative to 1KE, C, total exercise 
volume (kg · repetitions) per leg and D, 
total exercise volume for 1LP and 2LP−leg 
relative to 1KE. Data are means with 95% 
confidence levels. 1KE, one‐legged knee 
extension; 1LP, one‐legged leg press; 2LP, 
two‐legged leg press; 2LP−leg, two‐legged 
leg press divided by two; COPD, chronic 
obstructive pulmonary disease; HC, healthy 
control. *Significant difference between 
groups (P < .05); #significant different from 
1KE (P < .05); £significant different from 
1LP (P < .05)
   | 31MØLMEN Et aL.
is likely due to suboptimal muscle functionality,19 the exag-
gerated reductions seen in COPD in two‐legged leg press is 
likely due to the cardiopulmonary limitations inherent to the 
disease.29 This agrees with previous data on endurance‐5 and 
resistance‐like exercises.22,23 Overall, these data underline 
the suitability of one‐legged resistance exercises in subjects 
with COPD, advocating their use in rehabilitation programs.
Overall, COPD subjects displayed lower muscular per-
formance in all exercises compared to healthy controls (total 
repetitions to exhaustion, −23%, −24%, and −49% for 1KE, 
1LP, and 2LP, respectively; overall exercise volume, −41%, 
−42%, and −56% for 1KE, 1LP, and 2LP, respectively). The 
reduced performance in one‐legged knee extension corrob-
orates with previous observations of ~30% reductions in 
one‐legged knee extension performance in subjects with 
moderate COPD compared to healthy controls.30,31 For one‐
legged exercises, the attenuation in muscular performance 
is likely due to the muscle pathophysiology inherent to the 
disease, including reduced proportions of type I muscle fi-
bers, increased proportions of type II (specially IIX) fibers, 
and reduced oxidative capacity.19,32,33 Furthermore, the pre-
vious studies have shown that subjects with moderate to se-
vere COPD (such as the participants in this study) are not 
limited by ventilatory capacity during one‐legged knee ex-
tension exercises.5,34 Our data supports this perspective, with 
COPD and healthy control subjects showing similar increases 
in muscular performance going from one‐legged knee exten-
sion to one‐legged leg press. This increase occurred without 
concomitant increase in lactate concentration, suggesting that 
oxygen supply was sufficient to fuel the increase in working 
muscle mass in one‐legged leg press.
Chronic obstructive lung disease subjects were unable 
to increase muscular performance going from one‐legged 
leg press to two‐legged leg press. This contrasts data from 
healthy controls, who displayed 65% and 52% increases in 
performance (repetitions and volume, respectively), and 
agrees with data from previous studies.35-38 In effect, this 
led to an exaggerated difference between COPD and healthy 
control subjects in muscular performance in two‐legged leg 
press, which cannot be attributed muscular dysfunctions. 
Instead, the causative explanation likely resides in the car-
diopulmonary limitations inherent to the COPD disease. 
Unfortunately, we do not have cardiorespiratory measure-
ments to support this view. However, it is logical that the 
increase in working muscle mass accompanying going from 
one‐legged leg press to two‐legged leg press led to oxygen 
requirements that surpassed the oxygen‐delivery capacity 
of the cardiopulmonary system, hence impairing muscle 
function and performance. This is supported by data from 
Nyberg et al,23 who found evidence for ventilatory lim-
itation in COPD patients at workloads corresponding to 
two‐legged knee extension exercise. There, a decrease in 
muscular performance−leg for COPD subjects was present 
going from one‐ to two‐limb exercises, but whether this 
decrease was different from what the healthy subjects ex-
perienced was not evaluated. Nyberg et al23 performed 
their study on COPD patients with more severe pulmonary 
obstruction (38% vs 53% of predicted FEV1), which may 
explain the absence of impaired muscular performance in 
one‐legged leg press in the present data. In our study, the 
crossing point between exercising with sufficient amounts 
of oxygen and exercising with insufficient amounts of ox-
ygen occurred around or slightly after activation of muscle 
mass corresponding to one‐legged leg press.
In the present data set, a comparison of 1RM data from 
healthy subjects and COPD provides an unexpected obser-
vation. In healthy controls, 1RM−leg in two‐legged leg press 
was 6% lower than 1RM in one‐legged leg press (though 
without reaching statistical significance). This phenom-
enon is frequently described in the literature and is coined 
the bilateral deficit.39 In contrast, in COPD, 1RM−leg in 
two‐legged leg press was 5% higher (non‐significant) than 
1RM in one‐legged leg press, suggesting that the bilateral 
deficit was absent in these patients. This is not common, but 
has been previously observed in populations such as well‐
trained individuals.40,41 This absence of a bilateral deficit in 
COPD is likely due to underperformance in one‐legged leg 
press 1RM tests (and not overperformance in two‐legged leg 
T A B L E  2  Physiological responses to muscular performance tests
 
One‐legged knee extension One‐legged leg press Two‐legged leg press
COPD Healthy
b/w 
groups COPD Healthy
b/w 
groups COPD Healthy
b/w 
groups
SpO2 (% change) −3.0 ± 2.1 −2.0 ± 1.0 P = .16 −3.1 ± 2.0 −1.3 ± 1.0 P = .01 −3.6 ± 2.9 −1.4 ± 1.2 P = .03
[BLa−] (% change) 236 ± 101 365 ± 225 P = .10 240 ± 108 352 ± 162 P = .07 355 ± 83*,** 539 ± 278 P = .05
Degree of dyspnea 
(0‐10)
4.5 ± 2.1 2.9 ± 0.8 P = .02 5.6 ± 1.6* 3.9 ± 1.2 P = .01 6.3 ± 1.6* 4.4 ± 1.6* P = .01
Note: SpO2 and [BLa−] values are presented as percentage change from rest. All values presented as means ± standard deviations.
[BLa−], blood lactate concentration; degree of dyspnea (1‐10); b/w, between; SpO2, oxygen saturation of hemoglobin.
*Significant different from one‐legged knee extension (P < .05). 
**Significant different from one‐legged leg press (P < .05). 
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press), perhaps related to poor technical performance caused 
by instability of the exercising limb or psychological factors. 
Regardless of causation, this phenomenon may have affected 
muscular performance during one‐legged leg press testing, 
arguably lowering loads corresponding to 60% of 1RM and 
increasing estimates of muscular performance measured as 
repetitions to exhaustion,38 potentially disguising impairing 
effects of cardiopulmonary limitations. Accordingly, for this 
exercise, there was no difference between COPD and healthy 
subjects in repetitions to exhaustion at 60% of 1RM (P = .10). 
This indirectly supports the notion that 1RM estimates for 
one‐legged leg press were too low, as each of the two other 
exercises revealed clear reductions in muscular performance 
in COPD compared to healthy controls. Indeed, after taking 
into account workload (ie, exercise volume), one‐legged leg 
press was also associated with marked reductions in muscu-
lar performance in COPD. Importantly, this potential issue 
does not change the take‐home message in our data: muscular 
performance in COPD subjects is impaired in two‐legged leg 
press, advocating the use of resistance exercises with lower 
amounts of active muscle mass.
4.1 | Perspectives
We have shown that COPD subjects display impaired muscu-
lar performance in resistance exercises compared to healthy 
controls. This impairment was exacerbated in exercises in-
volving larger amounts of muscle mass (>one‐legged leg 
press), suggesting that performance in such exercises was 
negatively influenced by the cardiopulmonary limitations in-
herent to the disease. A similar observation has previously 
been made in COPD patients with more severe diagnoses,22,23 
but not in the present patient population and not in connec-
tion with isolated resistance exercises performed in appara-
tus. This is also the first study to explicitly show that COPD 
patients show progressively lowered muscular performance 
in resistance exercises compared to healthy controls. Our 
data advocate implementation of resistance exercises target-
ing smaller amounts of muscle mass into rehabilitation pro-
grams for COPD subjects, including one‐legged exercises.
Importantly, in healthy adults, one‐legged resistance 
training leads to similar improvements of muscle functions 
as two‐legged training, measured as strength and hypertro-
phy.42-44 For COPD patients, there seems to be “a thresh-
old” of muscle mass that can be exercised before muscular 
performance is limited by the cardiopulmonary capacity. In 
our study, this threshold seemed to occur around the mus-
cle mass needed to perform one‐legged leg press, though 
this remains circumstantial, as it was beyond the scope 
of the project to set such a threshold. Adding to this, the 
threshold is probably of individual character, determined 
by the subjects’ cardiorespiratory capacity and the severity 
of the disease. Based on our data, we cannot conclude that 
one‐legged resistance training will bring higher efficacy 
to COPD rehabilitation, which may resolve the seemingly 
lowered responses to training observed in this popula-
tion. However, such training may enable COPD patients 
to perform resistance training on equal terms as healthy 
individuals, freeing them from the obstructions of cardio-
pulmonary limitations. Future studies should aim to target 
this perspective.
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